Thriva Stock
Thriva offers a personalized at-home finger-prick blood test which enables individuals to easily track and improve health.
Sign up today and learn more about Thriva Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Thriva Stock
Thriva offers a personalized at-home finger-prick blood test which enables individuals to easily track and improve health. All tests are analyzed by their partner laboratory and results are reviewed by their in-house Doctor (a qualified GP of 7 years). Thriva also helps users understand what they need to focus on to make improvements. It was founded in 2015.
Funding History
| June 2017 | $1.5M |
|---|---|
| July 2019 | $6.0M |
| May 2020 | $4.5M |
Management
Investor
Will Neale
Co-Founder & COO
Eliot Brooks
CEO & Co-Founder
Hamish Grierson
Co-Founder & CTO
Tom Livesey
Press
digitalhealth - Dec, 24 2023
Digital Health Coffee Time Briefingbusinesswire - May, 16 2023
Thriva Becomes a CQC Registered Company as it Launches Membership Model Thriva+thetimes - Jul, 1 2022
Thrivavisugram - Nov, 30 2021
Top 25 MedTech Startupssplento - Sep, 27 2021
Top 25 MedTech StartupsEquityZen Recognized As:
